Dantam Inc. – Trademark Portfolio

Entity Type: 03

Dantam Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 3 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include AIDM and AIDM AUSTIN INSTITUTE OF DENTAL MEDICINE. The owner is based in Austin, TX.

9901 Brodie Lane

Ste. 160

Austin, TX 78748

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Dantam Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

41
Education & Entertainment (3 filings)

Education; providing of training; entertainment; sporting and cultural activities

44
Medical Services (3 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Dantam Inc. have?

Dantam Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending.

What trademark classes does Dantam Inc. file in?

Dantam Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.

What are Dantam Inc.'s most well-known trademarks?

Dantam Inc.'s registered trademark portfolio includes well-known marks such as AIDM and AIDM AUSTIN INSTITUTE OF DENTAL MEDICINE. These are among 2 currently registered trademarks in the portfolio.

What is Dantam Inc.'s trademark registration success rate?

Dantam Inc. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.